Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- University of Nottingham
- Cranfield University
- ;
- University of Cambridge
- ; Swansea University
- ; University of Nottingham
- ; Loughborough University
- ; The University of Edinburgh
- ; The University of Manchester
- KINGS COLLEGE LONDON
- UNIVERSITY OF VIENNA
- ; City St George’s, University of London
- ; University of Birmingham
- ; University of Exeter
- ; University of Oxford
- ; University of Plymouth
- ; University of Warwick
- Durham University;
- Imperial College London
- University of Exeter
- University of Sheffield
- ; Brunel University London
- ; Coventry University Group
- ; Cranfield University
- ; Imperial College London
- ; Newcastle University
- ; University of Bristol
- ; University of Cambridge
- ; University of East Anglia
- ; University of Southampton
- ; University of Strathclyde
- AALTO UNIVERSITY
- Abertay University
- Harper Adams University
- Kingston University
- Newcastle University
- The University of Manchester
- UCL
- University of Birmingham
- University of Bristol
- University of Hertfordshire
- University of Liverpool
- University of Plymouth
- University of Warwick
- University of Warwick;
- 35 more »
- « less
-
Field
-
research will focus on contributing to the design of this network and verification of its performance, or specific aspects of it. It may involve, as one component of the research, developing the Claims
-
receptor, and human epidermal growth factor receptor 2 expression. Therefore, TNBC is characterised by aggressive clinical behaviour, and inherent resistance to conventional chemotherapy. Recently
-
to the selection stage on the week commencing7th July 2025. If you need any support, equipment or adjustments to enable you to participate in any element of the recruitment process you can contact Joanne Turner
-
simulations to improve on existing power usage models. This research will be a key component of making computing more sustainable by providing novel insights into the energy usage of scientific software and
-
prodromic stage of PD. Despite this, the mechanism underlying PD-related cardiac ANS degeneration is unknown. The Ala30Pro (A30P) missense mutation in the alpha-synuclein protein is a genetic risk factor of
-
propellants potentially pose a risk during the proximity operations a kick stage would undertake, for example, condensing on sensitive surfaces such as solar arrays and optical or other sensors
-
), or a Master’s degree from a relevant discipline with a substantial quantitative component (such as medical/biomedical sciences, epidemiology, public health, health data science). Experience or interest
-
, please visit our website at https://www.cruk.cam.ac.uk/ Project details Being overweight is a known risk factor for developing breast cancer, and obese patients experience poorer outcomes. But
-
. Using detailed energy usage data from different industrial reference sites (offices, manufacturing facilities etc.) to examine what elements are affected by different weather scenarios, the project will
-
enhancers at repetitive GGAA DNA elements (GGAA microsatellites). These neo-enhancers appear to contribute to tumorigenesis and eventually tumour progression and possibly underlie germline variation